Literature DB >> 24976698

Breath tests and irritable bowel syndrome.

Satya Vati Rana1, Aastha Malik1.   

Abstract

Breath tests are non-invasive tests and can detect H₂ and CH₄ gases which are produced by bacterial fermentation of unabsorbed intestinal carbohydrate and are excreted in the breath. These tests are used in the diagnosis of carbohydrate malabsorption, small intestinal bacterial overgrowth, and for measuring the orocecal transit time. Malabsorption of carbohydrates is a key trigger of irritable bowel syndrome (IBS)-type symptoms such as diarrhea and/or constipation, bloating, excess flatulence, headaches and lack of energy. Abdominal bloating is a common nonspecific symptom which can negatively impact quality of life. It may reflect dietary imbalance, such as excess fiber intake, or may be a manifestation of IBS. However, bloating may also represent small intestinal bacterial overgrowth. Patients with persistent symptoms of abdominal bloating and distension despite dietary interventions should be referred for H₂ breath testing to determine the presence or absence of bacterial overgrowth. If bacterial overgrowth is identified, patients are typically treated with antibiotics. Evaluation of IBS generally includes testing of other disorders that cause similar symptoms. Carbohydrate malabsorption (lactose, fructose, sorbitol) can cause abdominal fullness, bloating, nausea, abdominal pain, flatulence, and diarrhea, which are similar to the symptoms of IBS. However, it is unclear if these digestive disorders contribute to or cause the symptoms of IBS. Research studies show that a proper diagnosis and effective dietary intervention significantly reduces the severity and frequency of gastrointestinal symptoms in IBS. Thus, diagnosis of malabsorption of these carbohydrates in IBS using a breath test is very important to guide the clinician in the proper treatment of IBS patients.

Entities:  

Keywords:  Bacterial overgrowth; Breath test; Carbohydrate malabsorption; Irritable bowel syndrome; Lactulose breath test; Small intestine; Sorbitol breath test

Mesh:

Substances:

Year:  2014        PMID: 24976698      PMCID: PMC4069289          DOI: 10.3748/wjg.v20.i24.7587

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  121 in total

Review 1.  Systemic lactose intolerance: a new perspective on an old problem.

Authors:  S B Matthews; J P Waud; A G Roberts; A K Campbell
Journal:  Postgrad Med J       Date:  2005-03       Impact factor: 2.401

2.  Sugar malabsorption in functional abdominal bloating: a pilot study on the long-term effect of dietary treatment.

Authors:  Fernando Fernández-Bañares; Mercé Rosinach; Maria Esteve; Montserrat Forné; Jorge C Espinós; Josep Maria Viver
Journal:  Clin Nutr       Date:  2006-01-10       Impact factor: 7.324

3.  Irritable bowel syndrome: is the search for lactose intolerance justified?

Authors:  T J Parker; J T Woolner; A T Prevost; Q Tuffnell; M Shorthouse; J O Hunter
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-03       Impact factor: 2.566

4.  Investigation of small bowel transit time in man utilizing pulmonary hydrogen (H2) measurements.

Authors:  J H Bond; M D Levitt; R Prentiss
Journal:  J Lab Clin Med       Date:  1975-04

5.  Methane production during lactulose breath test is associated with gastrointestinal disease presentation.

Authors:  Mark Pimentel; Andrew G Mayer; Sandy Park; Evelyn J Chow; Aliya Hasan; Yuthana Kong
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

6.  Does lactose maldigestion really play a role in the irritable bowel?

Authors:  B A Tolliver; M S Jackson; K L Jackson; E D Barnett; J F Chastang; J A DiPalma
Journal:  J Clin Gastroenterol       Date:  1996-07       Impact factor: 3.062

7.  [Predominance of constipation in subjects with hydrogen-consuming intestinal flora].

Authors:  Guillermo Dima; Daniel Peralta; Abel Novillo; Juan Lasa; Horacio Besasso; Luis Soifer
Journal:  Acta Gastroenterol Latinoam       Date:  2012-09

8.  Results of small intestinal bacterial overgrowth testing in irritable bowel syndrome patients: clinical profiles and effects of antibiotic trial.

Authors:  M Majewski; R W McCallum
Journal:  Adv Med Sci       Date:  2007       Impact factor: 3.287

9.  Use of pulmonary hydrogen (H 2 ) measurements to quantitate carbohydrate absorption. Study of partially gastrectomized patients.

Authors:  J H Bond; M D Levitt
Journal:  J Clin Invest       Date:  1972-05       Impact factor: 14.808

10.  Effect of dietary fiber on intestinal gas production and small bowel transit time in man.

Authors:  J H Bond; M D Levitt
Journal:  Am J Clin Nutr       Date:  1978-10       Impact factor: 7.045

View more
  15 in total

1.  Four-sample lactose hydrogen breath test for diagnosis of lactose malabsorption in irritable bowel syndrome patients with diarrhea.

Authors:  Jian-Feng Yang; Mark Fox; Hua Chu; Xia Zheng; Yan-Qin Long; Daniel Pohl; Michael Fried; Ning Dai
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

Review 2.  Irritable bowel syndrome.

Authors:  Paul Enck; Qasim Aziz; Giovanni Barbara; Adam D Farmer; Shin Fukudo; Emeran A Mayer; Beate Niesler; Eamonn M M Quigley; Mirjana Rajilić-Stojanović; Michael Schemann; Juliane Schwille-Kiuntke; Magnus Simren; Stephan Zipfel; Robin C Spiller
Journal:  Nat Rev Dis Primers       Date:  2016-03-24       Impact factor: 52.329

3.  Measurement of oro-caecal transit time by magnetic resonance imaging.

Authors:  Edoardo Savarino; Vincenzo Savarino; Mark Fox; Giovanni Di Leo; Manuele Furnari; Elisa Marabotto; Lorenzo Gemignani; Luca Bruzzone; Alessandro Moscatelli; Chiara De Cassan; Francesco Sardanelli; Luca Maria Sconfienza
Journal:  Eur Radiol       Date:  2015-01-11       Impact factor: 5.315

4.  Small bowel bacterial overgrowth in patients with irritable bowel syndrome: the first study in iran.

Authors:  Mehdi HayatBakhsh Abbasi; MohammadJavad Zahedi; Sodaif Darvish Moghadam; Sara Shafieipour; Mahroo HayatBakhsh Abbasi
Journal:  Middle East J Dig Dis       Date:  2015-01

Review 5.  Profile of rifaximin and its potential in the treatment of irritable bowel syndrome.

Authors:  Natalya Iorio; Zubair Malik; Ron Schey
Journal:  Clin Exp Gastroenterol       Date:  2015-06-08

6.  Obesity Is Inversely Related to Hydrogen-Producing Small Intestinal Bacterial Overgrowth in Non-Constipation Irritable Bowel Syndrome.

Authors:  Seung Eun Jung; Nam Seok Joo; Kyung Sun Han; Kyu Nam Kim
Journal:  J Korean Med Sci       Date:  2017-06       Impact factor: 2.153

7.  Patients with functional bowel disorder have disaccharidase deficiency: A single-center study from Russia.

Authors:  Saria Dbar; Olga Akhmadullina; Elena Sabelnikova; Nikolai Belostotskiy; Asfold Parfenov; Svetlana Bykova; Sergey Bakharev; Elena Baulo; Alexandra Babanova; Lilia Indeykina; Tatyana Kuzmina; Tatiana Kosacheva; Aleksey Spasenov; Alina Makarova
Journal:  World J Clin Cases       Date:  2021-06-16       Impact factor: 1.337

8.  Use of the Biphasic (13)C-Sucrose/Glucose Breath Test to Assess Sucrose Maldigestion in Adults with Functional Bowel Disorders.

Authors:  Antone R Opekun; Albert M Balesh; Harold T Shelby
Journal:  Biomed Res Int       Date:  2016-08-08       Impact factor: 3.411

9.  Role of Fructose Malabsorption in Patients With Irritable Bowel Syndrome.

Authors:  Young Kim; Chang Hwan Choi
Journal:  J Neurogastroenterol Motil       Date:  2018-04-30       Impact factor: 4.924

10.  Risk of small intestinal bacterial overgrowth in patients receiving proton pump inhibitors versus proton pump inhibitors plus prokinetics.

Authors:  Pruthvi C Revaiah; Rakesh Kochhar; Surinder V Rana; Neha Berry; Munish Ashat; Narendra Dhaka; Y Rami Reddy; Saroj K Sinha
Journal:  JGH Open       Date:  2018-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.